Tyra Biosciences
Tyra Biosciences is a clinical-stage biopharmaceutical company (NASDAQ: TYRA) based in Carlsbad, California, focused on developing next-generation precision medicines that address the emergence of tumor resistance and other challenges in existing treatment options. Tyra's proprietary in-house SNAP discovery platform combines advanced protein crystallography with structure-based drug design, producing full structural "SNAPshots" of the real-world interaction between a drug and its target in as little as seven days rather than weeks to months. This rapid, sequential structural iteration lets the team refine molecular designs to angstrom-level precision and design selective inhibitors intended to deliver deeper, more durable responses for patients, including in cancers where resistance mutations block first-generation drugs. Tyra was surfaced as a portfolio company of Canaan Partners. It is a therapeutics company and does not publish a public developer API, SDK, or API documentation surface.
Index entry only — little beyond a description and a link, and nothing machine-readable enough for an agent to act on without a human reading the site first.
API Evangelist profiles Tyra Biosciences the way a machine reads it — 1 machine-readable artifact, pulled from the provider's own public surface and indexed so a developer, an analyst, or an AI agent can evaluate it against every other provider on the network.
Every provider in the network is reduced to the same set of machine-readable artifacts — OpenAPI contracts, event specifications, GraphQL schemas, runnable collections, pricing and rate-limit signals, security posture, OAuth scopes, and the agent surfaces (MCP servers and skills) that let software drive the API on its own. We profile them because the interface is the part of a company you can actually inspect: it is a truer signal of what a provider does than any marketing page. From those artifacts we compute the Kin Score — Tyra Biosciences scores 14.6/100 (minimal), with a separate agent-readiness read of 0/100 (human only). The full breakdown is below, followed by every artifact we hold — each card links through to its machine-readable definition on apis.io.
Kin Score
This is the API Evangelist rating — a single, repeatable read computed from the artifacts on this page. Green fill is points earned; the red track is points possible, so every bar shows earned-versus-possible at a glance.
Kin Score
How this is scored →scored 2026-07-27 · rubric v0.5
How we profile Tyra Biosciences
Each block below is one kind of artifact we hold for Tyra Biosciences. For each we say what it is and why it earns a place in the profile, then list every one we've indexed — capped at two rows, scroll within the panel for the rest.
Security Posture 1
Authentication, domain security, vulnerability disclosure, and trust-center signals — the evidence that a provider takes security seriously enough to document it. We profile it because you can't govern what you can't see.
Authentication, domain security, vulnerability disclosure, and trust-center signals.
Resources
Every other property we hold for Tyra Biosciences — documentation, portals, status pages, policies, and corporate surface — grouped by the job it does, following the integrator's arc from getting started to running in production.
Access & Security 1
Authentication, authorization, and security posture
Operate 1
Status, limits, changes, and where to get help
Commercial 2
Pricing, plans, and the legal terms of use
Company 3
The organization behind the API
← All providers · Data indexed from github.com/api-evangelist/tyra · machine-readable index on apis.io